-
AbbVie Inc. (ABBV $220.68)
-
Danaher Corporation (DHR $185.38)
-
Eli Lilly and Company (LLY $723.52)
-
Thermo Fisher Scientific Inc (TMO $462.48)
-
Lantheus Holdings Inc. (LNTH $50.22)
Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?